Updates matching "Cancer Research"

In late May, the Office of Management and Budget (OMB) released a proposed rule that would fundamentally change how federal grants and contracts would be awarded and managed, opening the door for interference and jeopardizing federal research investments. These changes would affect work funded by the National Institutes

WASHINGTON, D.C. – Cancer survivors, researchers and advocates, including Lynne Nacke of Birmingham, will travel to Capitol Hill on May 21 to deliver a message to Congress: America’s progress against cancer is working but continued investment is essential to save more lives. The advocates represent researchers developing the next

A new bill that would improve access to clinical trials was recently introduced in the U.S. Senate. Sponsored by Senators Tim Scott (R-S.C.) and Mark Warner (D-Va.), the Clinical Trial Modernization Act (S. 4440) would help reduce cost and geographic barriers, making it easier for patients to take part in clinical trials. U.S. Representatives Raul Ruiz (D-Calif.) and August Pfluger (R-Texas) introduced the House version (H.R. 3521) of this legislation in May 2025.

As the administration releases its proposed budget for Fiscal Year 2027, the American Cancer Society Cancer Action Network (ACS CAN) is calling on Congress to maintain its longstanding bipartisan commitment to robust, increased investments in cancer research and prevention.

This week, Congress officially passed its FY26 appropriations bill that delivers major wins in the fight against cancer and reinforces that cancer remains a national priority. The package includes critical investments in cancer research and prevention programs, advancements in childhood cancer care, passage of the Nancy Gardner Sewell

New federal legislation that would make it easier for all cancer patients to participate in clinical trials was introduced today in the House of Representatives. Sponsored by U.S. Reps. Raul Ruiz (D-Calif.) and August Pfluger (R-Texas), the Clinical Trial Modernization Act would help remove cost and geographic hurdles that prevent patients from participating in clinical trials.